Cardlytics Revenue vs. Net Income
| CDLX Stock | USD 0.67 -0.03 -4.29% |
Total Revenue | First Reported 2015-06-30 | Previous Quarter 52 M | Current Value 56.1 M | Quarterly Volatility 19.9 M |
Macro event markers
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.3 | 0.4505 |
|
|
The view summarizes Cardlytics profitability using ratios that relate earnings to revenue, assets, and equity.
Cardlytics | Build AI portfolio with Cardlytics Stock |
Macro event markers
Quarterly Earnings Growth -0.57 | Earnings Share -1.95 | Revenue Per Share | Quarterly Revenue Growth -0.24 | Return On Assets |
Understanding Cardlytics includes distinguishing between market value and book value, where book value reflects Cardlytics's accounting equity. Cardlytics' market capitalization is 37.15 M. A P/B ratio of 1.58 indicates the market values Cardlytics above its accounting book value. Enterprise value stands at 203.87 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Cardlytics' value from its trading price, which are computed with different methods. For Cardlytics, key inputs include a P/B ratio of 1.58, a profit margin of -44.36%, ROE of -3.26%, and revenue of 233.27 M. By contrast, market price reflects the level where buyers and sellers transact.
Cardlytics Net Income vs. Revenue Fundamental Analysis
Peer multiple analysis evaluates Cardlytics's pricing efficiency within its industry. Cardlytics is rated second in revenue among leading competitors. It is rated below average in net income among leading competitors . Total Revenue is currently estimated at 225.53 Million, marking a shift of 3.44%. Cardlytics reported 233.27 Million in Total Revenue for the previous period. Earnings multiples remain central to Cardlytics' valuation analysis.Cardlytics Revenue vs. Competition
Cardlytics is rated second in revenue among leading competitors. Market size based on revenue of Communication Services industry is currently estimated at about 2.17 Billion. Cardlytics retains roughly 233.27 Million in revenue claiming about 11% of market share in Communication Services space.
Cardlytics Net Income vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Cardlytics |
| = | 233.27 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Cardlytics |
| = | -103.49 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Cardlytics Net Income Comparison
Cardlytics is currently under evaluation in net income among leading competitors.
Cardlytics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cardlytics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cardlytics will eventually generate negative long term returns. The profitability progress is the general direction of Cardlytics' change in net profit over the period of time. It can combine multiple indicators of Cardlytics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -2 M | -1.9 M | |
| Interest Income | 2.7 M | 3.2 M | |
| Operating Income | -47.1 M | -49.5 M | |
| Net Loss | -103.5 M | -108.7 M | |
| Income Before Tax | -103.5 M | -108.7 M | |
| Total Other Income Expense Net | -56.3 M | -53.5 M | |
| Net Loss | -418.7 M | -397.8 M | |
| Net Loss | -103.5 M | -108.7 M | |
| Income Tax Expense | 154.9 M | 162.7 M | |
| Net Interest Income | -7.9 M | -8.3 M | |
| Non Operating Income Net Other | -7.3 M | -7 M | |
| Change To Netincome | 433.9 M | 455.6 M | |
| Net Loss | -1.95 | -2.05 | |
| Income Quality | -0.09 | -0.09 | |
| Net Income Per E B T | 1.15 | 1.08 |
Cardlytics Profitability Driver Comparison
Investors in Cardlytics should monitor its profitability drivers closely, as these factors directly influence long-term investment value. Unexpected events - from macroeconomic disruptions to industry shocks - can significantly alter Cardlytics' earnings outlook and broader investment thesis.
Earnings per Share Projection vs Actual
Use Cardlytics in pair-trading
Pair trading with Cardlytics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Cardlytics Pair Trading
Cardlytics Pair Trading Analysis
The effectiveness of tax-loss harvesting on Cardlytics depends on finding a suitable replacement asset. Instruments with correlation above 0.9 to Cardlytics typically provide adequate market exposure during the required holding period.
Interpreting the correlation table for Cardlytics: readings above 0.8 indicate strongly correlated pairs with minimal diversification benefit, while readings between -0.2 and +0.2 around Cardlytics suggest near-independence and genuine portfolio diversification value.
Use Correlation analysis and pair trading evaluation for Cardlytics to review hedging context. The view can be extended across sectors or other related groups.Use Investing Themes to Complement your Cardlytics position
Using Cardlytics inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
More Resources for Cardlytics Stock Analysis
A comprehensive view of Cardlytics starts with financial statements and ratio context. Key ratios help frame profitability, efficiency, and growth context for Cardlytics Stock. Key reports that frame Cardlytics Stock are listed below:Trending Equities. Our How to Invest in Cardlytics guide provides practical guidance on trading Cardlytics Stock.Analysis related to Cardlytics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Projecting Cardlytics' profitability begins with historical financial statements. The three primary statements are income statement, balance sheet, and cash flow.